However, the anti-tumor effect was still hindered by low drug loading efficiency of 2.5 ± 0.05 pg/cell26, which is potentially attributed to the efflux outside the cells by the P-glycoprotein overexpressed on MSCs. The gene discussed is ABCB1; the disease is neoplasm.